COVID-19 Indian Perspectives and Challenges: The TIP Approach
Abstract
No abstract
References
1. Coronavirus: World Health Organization 2020. https:// www.who.int/health-topics/coronavirus#tab=tab_1
2. Kucharski AJ, Russel TW, Diamond C, Liu Y, Edmunds J, Funk S et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect Dis 2020; published online March 11. https://www.thelancet. com/journals/laninf/article/PIIS1473-3099(20)30144-4/
fulltext
3. Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis. Int J Infect Dis. 2020 Feb 22;93:201-204. https://www.ncbi.nlm.nih.gov/ pubmed/32097725
4. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S et al.. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Mar 13. https://www.ncbi.nlm.nih.gov/pubmed/32167524
5. Ruan S. Likelihood of survival of Coronavirus disease 2019. The Lancet, March 30, 2020. https://www.thelancet.com/ journals/laninf/article/PIIS1473-3099(20)30257-7/fulltext
6. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Maihe M et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. March 20, 2020. https://www.sciencedirect. com/science/article/pii/S0924857920300996
7. Bhatnagar T, Murhekar MV, Soneja M, Gupta N, Giri S, Wig N et al. Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use. Indian Journal of Medical Research, March 2020 online. http:// www.ijmr.org.in/preprintarticle.asp?id=280484;type=0
8. World Health Organization SOLIDARITY Trial 2020. https://www.who.int/emergencies/diseases/novel-coronavirus- 2019/global-research-on-novel-coronavirus-2019-ncov/ solidarity-clinical-trial-for-covid-19-treatments
9. Yamey G, Schaferhoff M, Hatchett R, Pate M, Zhao F, McDade KK, et al. Ensuring Global access to COVID-19 vaccines. The Lancet, published March 31, 2020. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30763-7/fulltext
10. Ministry of Health and Family Welfare and Indian Council of Medical Research COVID-2019 guidelines and advisories. https://www.mohfw.gov.in/
11. Narayanan V. Enhancing Health Care in India – What to Expect in the Coming Decade? The Indian Practitioner q Vol.73 No.1. January 2020. http://articles.theindianpractitioner. com/index.php/tip/article/view/911
12. Accelerated Emergency Use Authorization (EUA) Summary COVID-19 RT-PCR Test. 2020. https://www.fda.gov/media/ 136151/download
13. Ministry of Health and Family Welfare and Indian Council of Medical Research COVID-2019 https://www.mohfw.gov. in/pdf/Advisory&StrategyforUseofRapidAntibodyBased- BloodTest.pdf
14. Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P et al. Sensitivity of Chest CT for COVID-19: Comparison to RTPCR. RSNA Radiology Feb 19, 2020. https://pubs.rsna.org/ doi/10.1148/radiol.2020200432
15. Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts. WHO Interim guidance Feb 2020. https://www.who.int/publications- detail/home-care-for-patients-with-suspected-novelcoronavirus-( ncov)-infection-presenting-with-mild-symptoms-
and-management-of-contacts
16. COVID-19: Testing, treatment free for Ayushman Bharat beneficiaries at private labs, empaneled hospitals. Economic Times, India 4th April 2020. https://economictimes.indiatimes. com/news/politics-and-nation/covid-19-testing-treatment- free-for-ayushman-bharat-beneficiaries-at-pvt-labsempanelled-
hospitals/articleshow/74986228.cms
17. Narayan VM, Hegarty P, Giannarini G, Bangs R, Chisolm S, Kamat AM. Beyond Bladder Cancer: Bacillus Calmette- Guérin (BCG) Vaccination Revisited as a Strategy to Reduce COVID-19 Related Adverse Events in High Risk Health Care Workers and the Elderly. Urotoday, 2nd April 2020.
ttps://www.urotoday.com/library-resources/ bladder-cancer/120412-beyond-bladder-cancer-bacillus- calmette-guerin-bcg-vaccination-revisited-as-a-strategy-
to-reduce-covid-19-hospitalization-in-the-elderly.html
18. AarogyaSetu Mobile app, Government of India 2020. https:// www.mygov.in/aarogya-setu-app/
19. Advisory on the use of Hydroxychloroquine as prophylaxis for SARS-CoV-2 infection. National Task Force, ICMR. 2020. https://www.mohfw.gov.in/pdf/AdvisoryontheuseofHydroxychloroquinasprophylaxisforSARSCoV2infection. pdf
20. Interim U.S. Guidance for Risk Assessment and Public Health Management of Healthcare Personnel with Potential Exposure in a Healthcare Setting to Patients with Coronavirus Disease (COVID-19). Centers for Disease Control and Prevention. CDC March 7, 2020. https://www.cdc.gov/coronavirus/ 2019-ncov/hcp/guidance-risk-assesment-hcp.html
2. Kucharski AJ, Russel TW, Diamond C, Liu Y, Edmunds J, Funk S et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect Dis 2020; published online March 11. https://www.thelancet. com/journals/laninf/article/PIIS1473-3099(20)30144-4/
fulltext
3. Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis. Int J Infect Dis. 2020 Feb 22;93:201-204. https://www.ncbi.nlm.nih.gov/ pubmed/32097725
4. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S et al.. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Mar 13. https://www.ncbi.nlm.nih.gov/pubmed/32167524
5. Ruan S. Likelihood of survival of Coronavirus disease 2019. The Lancet, March 30, 2020. https://www.thelancet.com/ journals/laninf/article/PIIS1473-3099(20)30257-7/fulltext
6. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Maihe M et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. March 20, 2020. https://www.sciencedirect. com/science/article/pii/S0924857920300996
7. Bhatnagar T, Murhekar MV, Soneja M, Gupta N, Giri S, Wig N et al. Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use. Indian Journal of Medical Research, March 2020 online. http:// www.ijmr.org.in/preprintarticle.asp?id=280484;type=0
8. World Health Organization SOLIDARITY Trial 2020. https://www.who.int/emergencies/diseases/novel-coronavirus- 2019/global-research-on-novel-coronavirus-2019-ncov/ solidarity-clinical-trial-for-covid-19-treatments
9. Yamey G, Schaferhoff M, Hatchett R, Pate M, Zhao F, McDade KK, et al. Ensuring Global access to COVID-19 vaccines. The Lancet, published March 31, 2020. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30763-7/fulltext
10. Ministry of Health and Family Welfare and Indian Council of Medical Research COVID-2019 guidelines and advisories. https://www.mohfw.gov.in/
11. Narayanan V. Enhancing Health Care in India – What to Expect in the Coming Decade? The Indian Practitioner q Vol.73 No.1. January 2020. http://articles.theindianpractitioner. com/index.php/tip/article/view/911
12. Accelerated Emergency Use Authorization (EUA) Summary COVID-19 RT-PCR Test. 2020. https://www.fda.gov/media/ 136151/download
13. Ministry of Health and Family Welfare and Indian Council of Medical Research COVID-2019 https://www.mohfw.gov. in/pdf/Advisory&StrategyforUseofRapidAntibodyBased- BloodTest.pdf
14. Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P et al. Sensitivity of Chest CT for COVID-19: Comparison to RTPCR. RSNA Radiology Feb 19, 2020. https://pubs.rsna.org/ doi/10.1148/radiol.2020200432
15. Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts. WHO Interim guidance Feb 2020. https://www.who.int/publications- detail/home-care-for-patients-with-suspected-novelcoronavirus-( ncov)-infection-presenting-with-mild-symptoms-
and-management-of-contacts
16. COVID-19: Testing, treatment free for Ayushman Bharat beneficiaries at private labs, empaneled hospitals. Economic Times, India 4th April 2020. https://economictimes.indiatimes. com/news/politics-and-nation/covid-19-testing-treatment- free-for-ayushman-bharat-beneficiaries-at-pvt-labsempanelled-
hospitals/articleshow/74986228.cms
17. Narayan VM, Hegarty P, Giannarini G, Bangs R, Chisolm S, Kamat AM. Beyond Bladder Cancer: Bacillus Calmette- Guérin (BCG) Vaccination Revisited as a Strategy to Reduce COVID-19 Related Adverse Events in High Risk Health Care Workers and the Elderly. Urotoday, 2nd April 2020.
ttps://www.urotoday.com/library-resources/ bladder-cancer/120412-beyond-bladder-cancer-bacillus- calmette-guerin-bcg-vaccination-revisited-as-a-strategy-
to-reduce-covid-19-hospitalization-in-the-elderly.html
18. AarogyaSetu Mobile app, Government of India 2020. https:// www.mygov.in/aarogya-setu-app/
19. Advisory on the use of Hydroxychloroquine as prophylaxis for SARS-CoV-2 infection. National Task Force, ICMR. 2020. https://www.mohfw.gov.in/pdf/AdvisoryontheuseofHydroxychloroquinasprophylaxisforSARSCoV2infection. pdf
20. Interim U.S. Guidance for Risk Assessment and Public Health Management of Healthcare Personnel with Potential Exposure in a Healthcare Setting to Patients with Coronavirus Disease (COVID-19). Centers for Disease Control and Prevention. CDC March 7, 2020. https://www.cdc.gov/coronavirus/ 2019-ncov/hcp/guidance-risk-assesment-hcp.html
Published
2020-04-27
How to Cite
Dr. Varsha Narayanan. (2020). COVID-19 Indian Perspectives and Challenges: The TIP Approach. The Indian Practitioner, 73(4), 7-10. Retrieved from https://articles.theindianpractitioner.com/index.php/tip/article/view/957
Section
Editorial
